Page last updated: 2024-11-03

risperidone and Local Neoplasm Recurrence

risperidone has been researched along with Local Neoplasm Recurrence in 1 studies

Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.

Research Excerpts

ExcerptRelevanceReference
" The incremental dosage of olanzapine from 5 to 20 mg/day was given but failed to control her psychotic symptoms during the first week, and was therefore switched to risperidone."1.42Chemotherapy-induced acute psychosis in a patient with malignant germ cell tumour. ( Pongpirul, K; Puangthong, U, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Puangthong, U1
Pongpirul, K1

Other Studies

1 other study available for risperidone and Local Neoplasm Recurrence

ArticleYear
Chemotherapy-induced acute psychosis in a patient with malignant germ cell tumour.
    BMJ case reports, 2015, Apr-09, Volume: 2015

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antipsychotic Agents; Benzodiazepines; Chemot

2015